Latest filing published 12 May 2026 for AbbVie Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Melody B. Meyer, listed as board member, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in AbbVie Inc. and NOV Inc. In total, 8 filings cover trades dated from 7 May 2021 to 8 May 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Most recently, on 12 May 2026, the filings show a share grant in AbbVie Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations